Perioperative Beta-Blocker Use for Noncardiac Surgery
Continuation of chronic beta-blocker therapy is recommended in the perioperative period. Routine initiation of perioperative beta-blockers solely to prevent postoperative atrial fibrillation or routine postoperative cardiovascular events is not recommended. Preoperative beta-blocker initiation, when indicated (e.g., for coronary disease/myocardial ischemia), should be started early enough to allow dose titration and assessment of tolerability, rather than starting immediately before surgery. [1] [2] [3]
Medication Selection Algorithm
Beta-blocker selection is based on whether therapy is continuation versus new initiation and on the cardiovascular indication.
- Continuation of chronic therapy
-
Continue the patient’s existing beta-blocker through the perioperative period. [3]
-
New initiation for coronary disease/myocardial ischemia
-
When oral beta-blockade is initiated in patients with coronary artery disease undergoing noncardiac surgery, atenolol or bisoprolol may be considered as first choices. [3]
-
Avoid routine “AF prevention” initiation
- Routine beta-blocker use for prevention of postoperative atrial fibrillation in noncardiac surgery is not recommended. 2024 AHA/ACC Perioperative Guideline-at-a-Glance
Core Recommendation With Guideline-Level Strength
Continuation of chronic beta-blockers
- Patients on chronic beta-blocker therapy should have therapy maintained in the perioperative period. [3]
- Per guideline review, increased mortality has been reported after preoperative withdrawal in observational studies. [3]
Routine perioperative initiation
- Routine initiation of beta-blockers in the perioperative period is not advised in the absence of an independent indication because benefit is uncertain and harms are real. [2]
- Routine beta-blocker use for prevention of postoperative atrial fibrillation in noncardiac surgery is not recommended. 2024 AHA/ACC Perioperative Guideline-at-a-Glance
Key Evidence Supporting These Recommendations
Harm signal for perioperative initiation in beta-blocker–naïve patients
- In POISE-1, extended-release metoprolol started shortly before surgery was associated with a lower composite outcome (5.8% vs 6.9%, P=0.04) but increased clinically significant hypotension or bradycardia and higher all-cause death and stroke risk in follow-up. [3]
Effect on postoperative atrial fibrillation (balanced by adverse effects)
- Meta-analysis evidence summarized in the ESC guideline indicates beta-blockers can reduce postoperative atrial fibrillation after noncardiac surgery, but increased bradycardia, hypotension, and stroke risk occurs. [3]
Monotherapy Versus Combination Therapy
Beta-blockers for postoperative atrial fibrillation prevention
- Routine prophylaxis with beta-blockers for postoperative atrial fibrillation is not recommended. 2024 AHA/ACC Perioperative Guideline-at-a-Glance
- Prophylactic regimens using short-acting beta-blockers initiated intraoperatively have uncertain timing benefit, and overall efficacy is inconsistent. [3]
Treatment Initiation Thresholds and Timing
When beta-blocker initiation is considered
- New initiation is generally not performed routinely.
- When oral beta-blockade is initiated for a coronary indication, the initiation strategy should allow tolerability testing and dose titration before surgery. [2] [3]
Practical timing (preoperative titration window)
- Beta-blockers may be initiated far enough before surgery that tolerability and drug titration can be performed, optimally >7 days before surgery. [4]
- A published clinical interpretation of the 2024 guideline recommends starting a beta-blocker at least 8 days before surgery when a new indication exists and not starting on the day of surgery. [5]
Postoperative management of tachycardia
- Postoperative tachycardia should prompt evaluation and treatment of underlying causes (e.g., hypovolemia, pain, blood loss, infection) rather than automatic beta-blocker dose escalation. [3]
Common Pitfalls to Avoid
- Starting high-dose, long-acting beta-blockers immediately before surgery in beta-blocker–naïve patients is associated with increased harm signals in outcome trials. [3]
- Withdrawing chronic beta-blockers for more than a short postoperative period increases atrial fibrillation risk. [3]
- Increasing beta-blocker doses without correcting perioperative contributors to tachycardia increases the risk of hypotension and bradycardia. [3]
Targets and Safety Monitoring in the Perioperative Period
- Perioperative beta-blocker therapy requires monitoring for bradycardia and hypotension, which are established adverse-event tradeoffs in the trial and meta-analysis evidence base. [3]
- Beta-blocker titration should be performed when beta-blocker initiation is indicated preoperatively to avoid peri-induction and early postoperative intolerance. [2] [4]
Cardiac Surgery Nuance (If Applicable)
- In adult cardiac surgery, perioperative beta-blocker continuation is commonly practiced because abrupt withdrawal can destabilize hemodynamics, and observational and guideline statements describe reduced new-onset postoperative atrial fibrillation with continuation. [6]